Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

New β-glucan inhibitors as antifungal drugs.

Hector RF, Bierer DE.

Expert Opin Ther Pat. 2011 Oct;21(10):1597-610. doi: 10.1517/13543776.2011.603899. Epub 2011 Jul 25. Review.

PMID:
21787240
2.

The public health impact of coccidioidomycosis in Arizona and California.

Hector RF, Rutherford GW, Tsang CA, Erhart LM, McCotter O, Anderson SM, Komatsu K, Tabnak F, Vugia DJ, Yang Y, Galgiani JN.

Int J Environ Res Public Health. 2011 Apr;8(4):1150-73. doi: 10.3390/ijerph8041150. Epub 2011 Apr 15. Review.

3.

Measuring cellular immunity in coccidioidomycosis: the time is now.

Ampel NM, Hector RF.

Mycopathologia. 2010 Jun;169(6):425-6. doi: 10.1007/s11046-010-9285-6. Epub 2010 Feb 16. No abstract available.

PMID:
20157783
4.

Safety, antigenicity, and efficacy of a recombinant coccidioidomycosis vaccine in cynomolgus macaques (Macaca fascicularis).

Johnson SM, Lerche NW, Pappagianis D, Yee JL, Galgiani JN, Hector RF.

Ann N Y Acad Sci. 2007 Sep;1111:290-300. Epub 2007 Mar 8.

PMID:
17347333
6.

An overview of antifungal drugs and their use for treatment of deep and superficial mycoses in animals.

Hector RF.

Clin Tech Small Anim Pract. 2005 Nov;20(4):240-9. Review.

PMID:
16317914
7.
8.

Coccidioidomycosis--a fungal disease of the Americas.

Hector RF, Laniado-Laborin R.

PLoS Med. 2005 Jan;2(1):e2. Review. No abstract available.

Supplemental Content

Loading ...
Support Center